BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26310563)

  • 1. RNAi-mediated knockdown of vascular endothelial growth factor inhibits vascularization and tumor growth in renal cell carcinoma.
    Gu M; Zhang K; Yao HJ; Zhou J; Peng YB; Xu MX; Wang Z
    Int J Mol Med; 2015 Oct; 36(4):1063-72. PubMed ID: 26310563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-Mediated RNAi Silencing of VEGF Inhibits Angiogenesis and Growth of Renal Cell Carcinoma in a Nude Mouse Xenograft Model.
    Lin J; Pang H; Guo X; Ding Y; Geng J; Zhang J; Min J
    DNA Cell Biol; 2015 Dec; 34(12):717-27. PubMed ID: 26465082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
    Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
    Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma.
    Zhou J; Zhang ZX; Zhao H; Zhu DM; Zhang Y; Li DC
    Technol Cancer Res Treat; 2011 Aug; 10(4):361-9. PubMed ID: 21728393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
    Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
    Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of COUP-TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cells.
    Zheng J; Qin W; Jiao D; Ren J; Wei M; Shi S; Xi W; Wang H; Yang AG; Huan Y; Wen W
    Int J Cancer; 2016 Oct; 139(7):1574-85. PubMed ID: 27193872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
    Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
    Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells.
    Wu MH; Huang CY; Lin JA; Wang SW; Peng CY; Cheng HC; Tang CH
    Oncogene; 2014 Mar; 33(13):1725-35. PubMed ID: 23584483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
    Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models.
    Chang YS; Adnane J; Trail PA; Levy J; Henderson A; Xue D; Bortolon E; Ichetovkin M; Chen C; McNabola A; Wilkie D; Carter CA; Taylor IC; Lynch M; Wilhelm S
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):561-74. PubMed ID: 17160391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.